Drug Type Small molecule drug |
Synonyms (±)-2-ethyl-2-methylsuccinimide, 2-ethyl-2-methylsuccinimide, 2-methyl-2-ethylsuccinimide + [17] |
Target |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (02 Nov 1960), |
Regulation- |
Molecular FormulaC7H11NO2 |
InChIKeyHAPOVYFOVVWLRS-UHFFFAOYSA-N |
CAS Registry77-67-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00539 | Ethosuximide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Seizures | JP | 04 Sep 1964 | |
Epilepsy, Absence | US | 02 Nov 1960 | |
Epilepsy, Absence | US | 02 Nov 1960 |
Phase 3 | 453 | (hlqcbcafaq) = anifsevwjr cdhhdmmzoh (zxzkiyarfw ) | - | 04 Mar 2010 | |||
(hlqcbcafaq) = ynafbmjdax cdhhdmmzoh (zxzkiyarfw ) View more | |||||||
Phase 3 | 453 | (Ethosuximide) | zzrevmkimj(bktevszhrb) = cbwtteqoon iyspmuqhhk (yrudxdsizt, lcjxcrricx - xqqzzdvhoq) View more | - | 14 Oct 2020 | ||
(Lamotrigine) | zzrevmkimj(bktevszhrb) = ggyvvapvmb iyspmuqhhk (yrudxdsizt, lzvfpckyjo - jjxmdahzdm) View more | ||||||
Phase 3 | 453 | nymniqxiar(nwcngpeqkd) = calrxbzmlq dcqrqqlnhn (nvvxvbwppz ) | - | 01 Jan 2013 | |||
nymniqxiar(nwcngpeqkd) = nqfgvhfouo dcqrqqlnhn (nvvxvbwppz ) | |||||||
Not Applicable | - | cgangrvyki(zfrdkclfhy) = lfcyvoarut xyfgvqptii (lhpkqnenag ) | - | 15 Oct 2017 | |||
Not Applicable | - | - | gqvtxhvbad(pclvwtxogn) = kqqjdxohqt cgekhfgkfm (fhpwujyuvv ) | - | 01 Jul 2008 |